Annual Total Liabilities
$12.14 M
+$6.91 M+132.15%
December 31, 2023
Summary
- As of February 27, 2025, MBRX annual total liabilities is $12.14 million, with the most recent change of +$6.91 million (+132.15%) on December 31, 2023.
- During the last 3 years, MBRX annual total liabilities has risen by +$873.00 thousand (+7.75%).
- MBRX annual total liabilities is now at all-time high.
Performance
MBRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$15.91 M
+$8.04 M+102.22%
September 30, 2024
Summary
- As of February 27, 2025, MBRX quarterly total liabilities is $15.91 million, with the most recent change of +$8.04 million (+102.22%) on September 30, 2024.
- Over the past year, MBRX quarterly total liabilities has stayed the same.
- MBRX quarterly total liabilities is now at all-time high.
Performance
MBRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MBRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +132.2% | 0.0% |
| 3 y3 years | +7.8% | +132.4% |
| 5 y5 years | +128.6% | +132.4% |
MBRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +138.3% | at high | +262.9% |
| 5 y | 5-year | at high | +138.3% | at high | +262.9% |
| alltime | all time | at high | +1471.4% | at high | +1527.3% |
Moleculin Biotech Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.91 M(+102.2%) |
| Jun 2024 | - | $7.87 M(-15.0%) |
| Mar 2024 | - | $9.26 M(-23.8%) |
| Dec 2023 | $12.14 M(+132.2%) | $12.14 M(+176.9%) |
| Sep 2023 | - | $4.38 M(-36.0%) |
| Jun 2023 | - | $6.85 M(+27.3%) |
| Mar 2023 | - | $5.38 M(+2.8%) |
| Dec 2022 | $5.23 M(+2.6%) | $5.23 M(-24.8%) |
| Sep 2022 | - | $6.96 M(+0.9%) |
| Jun 2022 | - | $6.90 M(+12.4%) |
| Mar 2022 | - | $6.14 M(+20.4%) |
| Dec 2021 | $5.10 M(-54.8%) | $5.10 M(-31.5%) |
| Sep 2021 | - | $7.44 M(-15.7%) |
| Jun 2021 | - | $8.83 M(-21.6%) |
| Mar 2021 | - | $11.27 M(-0.0%) |
| Dec 2020 | $11.27 M | $11.27 M(-11.1%) |
| Sep 2020 | - | $12.68 M(-19.5%) |
| Jun 2020 | - | $15.75 M(+54.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $10.18 M(+5.3%) |
| Dec 2019 | $9.66 M(+81.9%) | $9.66 M(-15.4%) |
| Sep 2019 | - | $11.42 M(+17.0%) |
| Jun 2019 | - | $9.76 M(+47.6%) |
| Mar 2019 | - | $6.62 M(+24.5%) |
| Dec 2018 | $5.31 M(+124.7%) | $5.31 M(-10.4%) |
| Sep 2018 | - | $5.93 M(-19.0%) |
| Jun 2018 | - | $7.32 M(+67.9%) |
| Mar 2018 | - | $4.36 M(+84.3%) |
| Dec 2017 | $2.37 M(+65.0%) | $2.37 M(+19.3%) |
| Sep 2017 | - | $1.98 M(+0.1%) |
| Jun 2017 | - | $1.98 M(-52.6%) |
| Mar 2017 | - | $4.17 M(+191.3%) |
| Dec 2016 | $1.43 M(+85.4%) | $1.43 M(+7.7%) |
| Sep 2016 | - | $1.33 M(-33.6%) |
| Jun 2016 | - | $2.00 M(+104.8%) |
| Mar 2016 | - | $978.00 K |
| Dec 2015 | $772.80 K | - |
FAQ
- What is Moleculin Biotech annual total liabilities?
- What is the all time high annual total liabilities for Moleculin Biotech?
- What is Moleculin Biotech annual total liabilities year-on-year change?
- What is Moleculin Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for Moleculin Biotech?
- What is Moleculin Biotech quarterly total liabilities year-on-year change?
What is Moleculin Biotech annual total liabilities?
The current annual total liabilities of MBRX is $12.14 M
What is the all time high annual total liabilities for Moleculin Biotech?
Moleculin Biotech all-time high annual total liabilities is $12.14 M
What is Moleculin Biotech annual total liabilities year-on-year change?
Over the past year, MBRX annual total liabilities has changed by +$6.91 M (+132.15%)
What is Moleculin Biotech quarterly total liabilities?
The current quarterly total liabilities of MBRX is $15.91 M
What is the all time high quarterly total liabilities for Moleculin Biotech?
Moleculin Biotech all-time high quarterly total liabilities is $15.91 M
What is Moleculin Biotech quarterly total liabilities year-on-year change?
Over the past year, MBRX quarterly total liabilities has changed by $0.00 (0.00%)